시장보고서
상품코드
1271287

세계의 요도협착 치료 시장 : 유형별, 치료법별(요도 확장술, 직하 요도 절개술, 요도 성형술, 기타), 질병 적응증별, 최종 사용자별, 지역별 - 규모, 점유율, 전망, 기회 분석(2023-2030년)

Urethral Stricture Treatment Market, By Type, By Treatment (Urethral Dilation, Direct Vision Internal Urethrotomy, Urethroplasty, Others), By Disease Indication, By End User, By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

발행일: | 리서치사: Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

요도협착은 감염이나 부상으로 인한 흉터로 인해 요도의 구경이 좁아지는 것을 말합니다. 요도 협착은 후방 요도 협착과 전방 요도 협착의 두 가지 유형이 있습니다. 후방 요도 협착은 후방 요도의 섬유화, 외상이나 골반 골절로 인한 타박상으로 인해 발생합니다. 전방 요도 협착은 가장 흔하게 발생하는 협착으로, 감염이나 외상으로 인한 해면체 섬유화로 인해 발생합니다. 이 증상은 요도직하내요도절개술(DVIU), 요도 성형술 등 다양한 치료법으로 치료할 수 있습니다. 요도협착의 주요 증상은 배뇨 장애 및 자극, 배뇨 시간 증가, 방광이 비어있는 듯한 불완전한 느낌입니다. 선진국 남성의 유병률은 0.9%로 추정됩니다. 폐쇄적이고 자극적인 배뇨 증상을 유발하고 궁극적으로 신장 기능을 저하시킬 수 있습니다. 요도 협착은 비뇨기과 진단 및 치료 절차로 인해 발생할 수 있습니다. 고령화 사회가 도래함에 따라 이러한 시술이 더욱 보편화되고 있으며, 따라서 요도 협착증도 더욱 보편화될 것으로 보입니다.

시장 역학

제품 포트폴리오를 확대하기 위해 시장에서 규제 당국의 승인과 같은 무기적인 성장 전략의 채택이 증가하고 있으며, 이는 예측 기간 동안 시장 성장을 가속할 것으로 예상됩니다. 예를 들어, 2022년 1월 비뇨기과, 부인과 등의 제품을 제공하는 의료 기술 기업인 Laborie.는 요도 약물 코팅 풍선(DCB)인 Optilume의 라이선스를 획득하고 미국 식품의약국(FDA)으로부터 제품 승인을 받았다고 발표했습니다.

본 조사의 주요 특징

  • 이 보고서는 2022년을 기준연도로 하여 예측 기간(2023-2030년) 시장 규모와 연평균 성장률(CAGR%)을 제시하는 세계 요도협착 치료제 시장을 상세히 분석했습니다.
  • 다양한 부문의 잠재적 수익 기회를 파악하고 이 시장에 대한 매력적인 투자 제안 매트릭스를 설명합니다.
  • 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 또는 승인, 시장 동향, 지역 전망 및 주요 기업이 채택한 경쟁 전략에 대한 중요한 고려 사항을 제공합니다.
  • 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 요도협착 치료 세계 시장 내 주요 기업 프로파일을 제공합니다.
  • 이 연구의 일부로 다뤄지는 주요 기업은 Becton, Dickinson and Company, Amecath, Zhejiang Chuangxiang, Medical Technology Co., Cook Group, Taewoong Medical Co., Ltd., Teleflex Incorporated, B. Braun Melsungen AG, Coloplast A/S, Boston Scientific Corporation, Pnn Medical A/이 보고서의 인사이트를 통해 마케터와 기업의 경영진은 향후 제품 출시, 제품 유형화, 제품 개발 및 마케팅에 대한 의사결정을 내릴 수 있을 것으로 기대됩니다. 향후 제품 출시, 유형 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
  • 요도 협착증 치료 세계 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통 업체, 신규 진출기업, 재무 분석가 등 이 업계의 다양한 이해 관계자에게 해당됩니다.
  • 이해관계자는 세계 요도협착 치료 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사 목적과 전제조건

  • 조사 목적
  • 전제조건
  • 약어

제2장 시장 전망

  • 보고서 개요
    • 시장 정의와 범위
  • 주요 요약
    • 시장 현황 : 유형별
    • 시장 현황 : 치료법별
    • 시장 현황 : 질환 적응증별
    • 시장 현황 : 최종사용자별
    • 시장 현황 : 지역별
  • Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
    • 영향 분석
    • 주요 하이라이트
    • 제품 발매
    • 기술적 진보
    • PEST 분석
    • 법규제 시나리오
    • 인수합병(M&A)

제4장 세계의 요도협착 치료 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

  • 경제적 영향
  • COVID-19 역학에 대해
  • 수급에 대한 영향

제5장 세계의 요도협착 치료 시장, 유형별, 2017년-2030년

  • 후방 요도협착
  • 전방 요도협착

제6장 세계의 요도협착 치료 시장, 치료법별, 2017년-2030년

  • 요도 확장술
  • 직하 요도 절개술(DVIU)
  • 요도 성형술
  • 문합 요도 성형술
  • 치환 요도 성형술
  • 기타

제7장 세계의 요도협착 치료 시장, 질환 적응별, 2017년-2030년

  • 의원성
  • 특발성
  • 감염증 유래
  • 외상
  • 기타

제8장 세계의 요도협착 치료 시장 : 최종사용자별, 2017년-2030년

  • 병원
  • 외래수술센터(ASC)
  • 기타

제9장 세계의 요도협착 치료 시장 : 지역별, 2017년-2030년

  • 북미
  • 미국
  • 캐나다
  • 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카
  • 유럽
  • 영국
  • 독일
  • 이탈리아
  • 프랑스
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 중국
  • 인도
  • 일본
  • ASEAN
  • 호주
  • 한국
  • 기타 아시아태평양
  • 중동
  • GCC
  • 이스라엘
  • 기타 중동
  • 아프리카
  • 북아프리카
  • 중앙아프리카
  • 남아프리카공화국

제10장 경쟁 구도

  • Becton, Dickinson and Company
  • Amecath
  • Zhejiang Chuangxiang Medical Technology Co., Ltd
  • Allium Ltd.
  • SURGIMEDIK
  • Cook Group
  • Teawoong Medical Co., Ltd.
  • Teleflex Incorporated
  • B. Braun Melsungen AG
  • Coloplast A/S
  • Boston Scientific Corporation
  • Pnn Medical A/S
  • Laborie.

제11장 섹션

  • 조사 방법에 대해
  • 출판사에 대해
LSH 23.05.26

Urethral stricture is the narrowing of the calibre of the urethra that is caused due to scarring resulting from infection or injury. There are two types of urethral strictures named posterior urethral stricture and anterior urethral stricture. Posterior urethral strictures occur due to fibrosis of the posterior urethra or distraction injuries that result from trauma or pelvic fractures. Anterior urethral stricture are the most commonly occurring strictures, and are caused due to infection or trauma leading to spongiofibrosis. The condition can be treated with various treatment options such as urethral direct vision internal urethrotomy (DVIU), urethroplasty, and other treatments. The main symptoms of urethral stricture are obstructed and irritated micturition, with increased urination time, and a feeling of incomplete bladder emptying. Its prevalence among men in industrial countries is estimated at 0.9%. It produces obstructive and irritative urinary symptoms, and can ultimately impair renal function. Urethral strictures can be caused by diagnostic or therapeutic urological procedures. These procedures are being performed more commonly, because the population is aging, and thus, urethral strictures will probably become more common as well.

Market Dynamics

Increasing adoption of inorganic growth strategies such as approvals by the regulatory authorities in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in January 2022, Laborie., a medical technology company thath provide products for urology, gynecology, and others, announced that it has received a license to the Optilume, a urethral drug coated balloon (DCB), laborite., and product is approved from U.S. Food and Drug Administration (FDA).

Key features of the study:

  • This report provides in-depth analysis of the global urethral stricture treatment market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global urethral stricture treatment market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study are Becton, Dickinson and Company, Amecath, Zhejiang Chuangxiang, Medical Technology Co., Ltd, Allium Ltd., SURGIMEDIK, Cook Group, Taewoong Medical Co., Ltd., Teleflex Incorporated, B. Braun Melsungen AG, Coloplast A/S, Boston Scientific Corporation, and Pnn Medical A/S. , and Laborie.Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global urethral stricture treatrment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global urethral stricture treatment market

Detailed Segmentation:

  • Global Urethral Stricture Treatment Market, By Type:
    • Posterior Urethral Stricture
    • Anterior Urethral Stricture
  • Global Urethral Stricture Treatment Market, By Treatment:
    • Urethral Dilation
    • Direct Vision Internal Urethrotomy (DVIU)
    • Urethroplasty
      • Anastomotic Urethroplasty
      • Substitution Urethroplasty
    • Others
  • Global Urethral Stricture Treatment Market, By Disease Indication:
    • Latrogenic
    • Idiopathic
    • Infection-induced
    • Trauma
    • Others
  • Global Urethral Stricture Treatment Market, By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Others
  • Global Urethral Stricture Treatment Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country:
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Becton, Dickinson and Company*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Amecath
    • Zhejiang Chuangxiang
    • Medical Technology Co., Ltd
    • Koninklijke Philips N.V.
    • Allium Ltd.
    • SURGIMEDIK
    • Cook Group
    • Taewoong Medical Co., Ltd.
    • Teleflex Incorporated
    • Braun Melsungen AG
    • Coloplast A/S
    • Boston Scientific Corporation
    • Pnn Medical A/S

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Treatment
    • Market Snapshot, By Disease Indication
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product Launches
    • Technological Advancements
    • PEST Analysis
    • Regulatory Scenario
    • Mergers and Acquisitions

4. Global Urethral Stricture Treatment Market- Impact of Coronavirus (Covid-19) Pandemic

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Urethral Stricture Treatment Market, By Type, 2017-2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Posterior Urethral Stricture
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Anterior Urethral Stricture
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Urethral Stricture Treatment Market, By Treatment, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Urethral Dilation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Direct Vision Internal Urethrotomy (DVIU)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Urethroplasty
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Anastomotic Urethroplasty
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017-2030, (US$ Million)
  • Substitution Urethroplasty
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017-2030, (US$ Million)

7. Global Urethral Stricture Treatment Market, By Disease Indication, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segments Trends
  • Latrogenic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Idiopathic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Infection-induced
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Trauma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017-2030, (US$ Million)

8. Global Urethral Stricture Treatment Market, By End User, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-O-Y Growth analysis, 2017 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2030, (US$) Million)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2030, (US$) Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2030, (US$) Million)

9. Global Urethral Stricture Treatment Market, By Region, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2017-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Becton, Dickinson and Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Amecath
  • Zhejiang Chuangxiang Medical Technology Co., Ltd
  • Allium Ltd.
  • SURGIMEDIK
  • Cook Group
  • Teawoong Medical Co., Ltd.
  • Teleflex Incorporated
  • B. Braun Melsungen AG
  • Coloplast A/S
  • Boston Scientific Corporation
  • Pnn Medical A/S
  • Laborie.

11. Section

  • Research Methodology
  • About Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제